世界の感染防止API産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Antiinfective API Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB10598)・商品コード:QYR20FB10598
・発行会社(調査会社):QYResearch
・発行日:2019年12月(※2024年版があります。お問い合わせください)
・ページ数:144
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD8,400 ⇒換算¥1,243,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界の感染防止API市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。感染防止APIの種類別には、呼吸器感染症API、皮膚感染症API、その他に、用途別には、経口薬、注射に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・感染防止APIの種類別市場規模:呼吸器感染症API、皮膚感染症API、その他
・感染防止APIの用途別市場規模:経口薬、注射
・感染防止APIの地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:ACS Dobfar、Sterile India、Nectar Lifesciences、Kopran、Qilu Pharmaceutial、Hangzhou Viwa、Daewoong Bio、Fresenius Kabi iPSUM、Sinopharm Weiqida Pharmaceutical、Virchow Healthcare、United Laboratories International Holdings、Dawnrays、CSPC Pharmaceutical、Orchid Pharma、Guangzhou Pi & Pi Biotech
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Anti-infective drugs refer to various drugs used to treat infections caused by pathogens. The API is the raw material made from these drugs.The Antiinfective API market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antiinfective API.

This study focuses on the production side and consumption side of Antiinfective API, presents the global Antiinfective API market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
In terms of production side, this report researches the Antiinfective API capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Antiinfective API by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
ACS Dobfar
Sterile India
Nectar Lifesciences
Kopran
Qilu Pharmaceutial
Hangzhou Viwa
Daewoong Bio
Fresenius Kabi iPSUM
Sinopharm Weiqida Pharmaceutical
Virchow Healthcare
United Laboratories International Holdings
Dawnrays
CSPC Pharmaceutical
Orchid Pharma
Guangzhou Pi & Pi Biotech

Market Segment by Product Type
Respiratory Infections API
Skin Infections API
Other

Market Segment by Application
Oral Medicine
Injection

Key Regions split in this report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Antiinfective API status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Antiinfective API manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antiinfective API are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antiinfective API Market Size Growth Rate by Type
1.3.2 Respiratory Infections API
1.3.3 Skin Infections API
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Antiinfective API Market Share by Application (2019-2025)
1.4.2 Oral Medicine
1.4.3 Injection
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Antiinfective API Production Value 2014-2025
2.1.2 Global Antiinfective API Production 2014-2025
2.1.3 Global Antiinfective API Capacity 2014-2025
2.1.4 Global Antiinfective API Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Antiinfective API Market Size CAGR of Key Regions
2.2.2 Global Antiinfective API Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Antiinfective API Capacity by Manufacturers
3.1.2 Global Antiinfective API Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Antiinfective API Revenue by Manufacturers (2014-2019)
3.2.2 Antiinfective API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antiinfective API Market Concentration Ratio (CR5 and HHI)
3.3 Antiinfective API Price by Manufacturers
3.4 Key Manufacturers Antiinfective API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antiinfective API Market
3.6 Key Manufacturers Antiinfective API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Respiratory Infections API Production and Production Value (2014-2019)
4.1.2 Skin Infections API Production and Production Value (2014-2019)
4.1.3 Other Production and Production Value (2014-2019)
4.2 Global Antiinfective API Production Market Share by Type
4.3 Global Antiinfective API Production Value Market Share by Type
4.4 Antiinfective API Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Antiinfective API Consumption by Application

6 Production by Regions
6.1 Global Antiinfective API Production (History Data) by Regions 2014-2019
6.2 Global Antiinfective API Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaAntiinfective API Production Growth Rate 2014-2019
6.3.2 North America Antiinfective API Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Antiinfective API Import & Export
6.4 Europe
6.4.1 Europe Antiinfective API Production Growth Rate 2014-2019
6.4.2 Europe Antiinfective API Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Antiinfective API Import & Export
6.5 China
6.5.1 China Antiinfective API Production Growth Rate 2014-2019
6.5.2 China Antiinfective API Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Antiinfective API Import & Export
6.6 Japan
6.6.1 Japan Antiinfective API Production Growth Rate 2014-2019
6.6.2 Japan Antiinfective API Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Antiinfective API Import & Export

7 Antiinfective API Consumption by Regions
7.1 Global Antiinfective API Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Antiinfective API Consumption by Type
7.2.2 North America Antiinfective API Consumption by Application
7.2.3 North America Antiinfective API Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Antiinfective API Consumption by Type
7.3.2 Europe Antiinfective API Consumption by Application
7.3.3 Europe Antiinfective API Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Antiinfective API Consumption by Type
7.4.2 Asia Pacific Antiinfective API Consumption by Application
7.4.3 Asia Pacific Antiinfective API Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Antiinfective API Consumption by Type
7.5.2 Central & South America Antiinfective API Consumption by Application
7.5.3 Central & South America Antiinfective API Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Antiinfective API Consumption by Type
7.6.2 Middle East and Africa Antiinfective API Consumption by Application
7.6.3 Central & South America Antiinfective API Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa

8 Company Profiles
8.1 ACS Dobfar
8.1.1 ACS Dobfar Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Antiinfective API
8.1.4 Antiinfective API Product Introduction
8.1.5 ACS Dobfar Recent Development
8.2 Sterile India
8.2.1 Sterile India Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Antiinfective API
8.2.4 Antiinfective API Product Introduction
8.2.5 Sterile India Recent Development
8.3 Nectar Lifesciences
8.3.1 Nectar Lifesciences Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Antiinfective API
8.3.4 Antiinfective API Product Introduction
8.3.5 Nectar Lifesciences Recent Development
8.4 Kopran
8.4.1 Kopran Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Antiinfective API
8.4.4 Antiinfective API Product Introduction
8.4.5 Kopran Recent Development
8.5 Qilu Pharmaceutial
8.5.1 Qilu Pharmaceutial Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Antiinfective API
8.5.4 Antiinfective API Product Introduction
8.5.5 Qilu Pharmaceutial Recent Development
8.6 Hangzhou Viwa
8.6.1 Hangzhou Viwa Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Antiinfective API
8.6.4 Antiinfective API Product Introduction
8.6.5 Hangzhou Viwa Recent Development
8.7 Daewoong Bio
8.7.1 Daewoong Bio Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Antiinfective API
8.7.4 Antiinfective API Product Introduction
8.7.5 Daewoong Bio Recent Development
8.8 Fresenius Kabi iPSUM
8.8.1 Fresenius Kabi iPSUM Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Antiinfective API
8.8.4 Antiinfective API Product Introduction
8.8.5 Fresenius Kabi iPSUM Recent Development
8.9 Sinopharm Weiqida Pharmaceutical
8.9.1 Sinopharm Weiqida Pharmaceutical Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Antiinfective API
8.9.4 Antiinfective API Product Introduction
8.9.5 Sinopharm Weiqida Pharmaceutical Recent Development
8.10 Virchow Healthcare
8.10.1 Virchow Healthcare Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Antiinfective API
8.10.4 Antiinfective API Product Introduction
8.10.5 Virchow Healthcare Recent Development
8.11 United Laboratories International Holdings
8.12 Dawnrays
8.13 CSPC Pharmaceutical
8.14 Orchid Pharma
8.15 Guangzhou Pi & Pi Biotech

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Antiinfective API Capacity, Production Forecast 2019-2025
9.1.2 Global Antiinfective API Production Value Forecast 2019-2025
9.2 Antiinfective API Production and Production Value Forecast by Regions
9.2.1 Global Antiinfective API Production Value Forecast by Regions
9.2.2 Global Antiinfective API Production Forecast by Regions
9.3 Antiinfective API Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Antiinfective API Production Forecast by Type
9.4.2 Global Antiinfective API Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Antiinfective API Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Antiinfective API Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Antiinfective API Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Antiinfective API Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Antiinfective API Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Antiinfective API Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antiinfective API Sales Channels
11.2.2 Antiinfective API Distributors
11.3 Antiinfective API Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer



【掲載企業】

ACS Dobfar、Sterile India、Nectar Lifesciences、Kopran、Qilu Pharmaceutial、Hangzhou Viwa、Daewoong Bio、Fresenius Kabi iPSUM、Sinopharm Weiqida Pharmaceutical、Virchow Healthcare、United Laboratories International Holdings、Dawnrays、CSPC Pharmaceutical、Orchid Pharma、Guangzhou Pi & Pi Biotech

★調査レポート[世界の感染防止API産業:成長傾向・競合分析2019-2025] (コード:QYR20FB10598)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の感染防止API産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆